MS Binding Assays for D1 and D5 Dopamine Receptors

Area of Science:

• Pharmacology
• Analytical Chemistry
• Neuroscience

Background:

• Radioligand binding assays are standard for determining drug affinity to receptors.
• Label-free alternatives offer potential advantages in assay development and execution.

Purpose of the Study:

• To develop and validate Mass Spectrometry (MS) binding assays for D1 and D5 dopamine receptors.
• To establish a sensitive LC-ESI-MS/MS method for quantifying the D1 antagonist SCH23390.

Main Methods:

• Development of a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method for SCH23390 quantification.
• Validation of the LC-ESI-MS/MS method using an 8-bromo analogue as an internal standard.
• Application of MS binding assay principles for saturation and competition binding experiments on D1 and D5 receptors.

Main Results:

• A highly sensitive, rapid, and robust LC-ESI-MS/MS method for SCH23390 was successfully established and validated.
• The developed MS binding assays accurately characterized SCH23390 binding to human D1 and D5 dopamine receptors.
• Experimental results demonstrated good agreement with established radioligand binding assay data.

Conclusions:

• MS binding assays are a suitable and effective label-free alternative to radioligand binding assays for D1 and D5 dopamine receptors.
• The developed methodology provides a robust platform for affinity determination of ligands targeting these receptors.
• This approach facilitates the characterization of dopamine receptor interactions, advancing neuroscience research.